1. Tinelli R, Tinelli A, Tinelli FG, Cicinelli E, Malvasi A. Conservative surgery for borderline ovarian tumors: a review. Gynecol Oncol. 2006; 100:185–191.
2. Kottmeier HL, Kolstad P, McGarrity KA. Annual report on the results of treatment in gynaecologic cancer vol 17, statements of results obtained in 1969-1972, inclusive. Stockholm, SE: Editorial office, Radiumhemmet: FIGO;1973.
3. Serov SF, Scully RE, Sobin LH. International histological classification of tumors, no 9 histoloigcal typing of ovarian tumours. Geneva, CH: World Health Organization;1973.
4. Morice P, Uzan C, Fauvet R, Gouy S, Duvillard P, Darai E. Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence. Lancet Oncol. 2012; 13:e103–e115.
5. Exacoustos C, Romanini ME, Rinaldo D, Amoroso C, Szabolcs B, Zupi E, et al. Preoperative sonographic features of borderline ovarian tumors. Ultrasound Obstet Gynecol. 2005; 25:50–59.
6. Sulkin TV, O'Neill H, Amin AI, Moran B. CT in pseudomyxoma peritonei: a review of 17 cases. Clin Radiol. 2002; 57:608–613.
7. Stewart JHt, Shen P, Levine EA. Intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: current status and future directions. Ann Surg Oncol. 2005; 12:765–777.
8. Kim CR, Ku CH, Jeon IS, Son DW, Lee JS. The clinicopathologic features and significance of preoperative CA 125 in patients who had an operation for ovarian tumors. J Korean Soc Menopause. 2013; 19:26–35.
9. Park JW, Bae JW. Postmenopausal Meigs' Syndrome in Elevated CA-125: A Case Report. J Menopausal Med. 2015; 21:56–59.
10. Kolwijck E, Thomas CM, Bulten J, Massuger LF. Preoperative CA-125 levels in 123 patients with borderline ovarian tumors: a retrospective analysis and review of the literature. Int J Gynecol Cancer. 2009; 19:1335–1338.
11. Carmignani CP, Hampton R, Sugarbaker CE, Chang D, Sugarbaker PH. Utility of CEA and CA 19-9 tumor markers in diagnosis and prognostic assessment of mucinous epithelial cancers of the appendix. J Surg Oncol. 2004; 87:162–166.
12. Liu JH, Zanotti KM. Management of the adnexal mass. Obstet Gynecol. 2011; 117:1413–1428.
13. Sherman ME, Berman J, Birrer MJ, Cho KR, Ellenson LH, Gorstein F, et al. Current challenges and opportunities for research on borderline ovarian tumors. Hum Pathol. 2004; 35:961–970.
14. Park JM, Kim MK. Hereditary risk evaluation for borderline ovarian tumors based on immunohistochemistry. J Menopausal Med. 2014; 20:14–20.
15. Kim TH, Lee HH, Hong JA, Park J, Jeon DS, Lee A, et al. Sclerosing stromal tumor in an elderly postmenopausal woman. J Menopausal Med. 2014; 20:80–83.
16. Park J, Kim TH, Lee HH, Lee W, Chung SH. Ovarian rete cyst in a post-menopausal woman: a case report. J Korean Soc Menopause. 2012; 18:67–69.